Prognostic factors for renal cell carcinoma: Trakya University experience from Turkey
dc.authorid | Cosar, Rusen/0000-0002-7953-8887 | |
dc.authorid | Puyan, Fulya/0000-0001-5853-0109 | |
dc.authorid | Cosar, Rusen/0000-0002-7953-8887 | |
dc.authorid | Oz Puyan, Fulya/0000-0001-5853-0109; | |
dc.authorwosid | Cosar, Rusen/AAC-4045-2020 | |
dc.authorwosid | Puyan, Fulya/V-7074-2019 | |
dc.authorwosid | Cosar, Rusen/GQP-7875-2022 | |
dc.authorwosid | Ibis, Kamuran/AAD-1939-2019 | |
dc.authorwosid | Oz Puyan, Fulya/A-7077-2018 | |
dc.authorwosid | Kocak, Zafer/AEG-7828-2022 | |
dc.contributor.author | Yurut-Caloglu, V. | |
dc.contributor.author | Caloglu, M. | |
dc.contributor.author | Kaplan, M. | |
dc.contributor.author | Oz-Puyan, F. | |
dc.contributor.author | Karagol, H. | |
dc.contributor.author | Ibis, K. | |
dc.contributor.author | Cosar-Alas, R. | |
dc.date.accessioned | 2024-06-12T11:12:55Z | |
dc.date.available | 2024-06-12T11:12:55Z | |
dc.date.issued | 2010 | |
dc.department | Trakya Üniversitesi | en_US |
dc.description.abstract | The purpose of the present study is to evaluate the prognostic factors of patients with renal cell carcinoma. The treatment results such as distant metastasis-free survival and overall survival of 59 previously untreated patients were retrospectively analysed. Median follow-up was 17.5 months (3.8-88.5 months). Overall survival was 22.4 months (3-87 months). Distant metastasis developed in 35 (59%) patients. The Eastern Cooperative Oncology Group (ECOG) performance status (P = 0.022), tumour size (P = 0.025) and lymphatic invasion (P < 0.0001) were significantly effective prognostic factors for distant metastasis-free survival on multivariate analysis. Related to overall survival, gender (P = 0.025), ECOG performance status (P = 0.027), nuclear grade (P = 0.002), tumour size (P = 0.029), T stage (P = 0.044), nodal involvement (P = 0.003), surgical margin (P = 0.046), renal sinus invasion (P < 0.0001), perineural growth (P = 0.001) and lymphatic invasion (P < 0.0001) were significant prognostic factors on univariate analysis. Gender (P = 0.008), ECOG performance status (P = 0.027), tumour size (P = 0.025) and lymphatic invasion (P < 0.0001) retained their significance on multivariate analysis. We concluded that the most important prognostic factors for patients with renal cell carcinomas are ECOG performance status, tumour size and lymphatic invasion. | en_US |
dc.identifier.doi | 10.1111/j.1365-2354.2009.01107.x | |
dc.identifier.endpage | 663 | en_US |
dc.identifier.issn | 0961-5423 | |
dc.identifier.issn | 1365-2354 | |
dc.identifier.issue | 5 | en_US |
dc.identifier.pmid | 19832896 | en_US |
dc.identifier.scopus | 2-s2.0-77955728703 | en_US |
dc.identifier.scopusquality | Q3 | en_US |
dc.identifier.startpage | 656 | en_US |
dc.identifier.uri | https://doi.org/10.1111/j.1365-2354.2009.01107.x | |
dc.identifier.uri | https://hdl.handle.net/20.500.14551/23363 | |
dc.identifier.volume | 19 | en_US |
dc.identifier.wos | WOS:000280993100019 | en_US |
dc.identifier.wosquality | Q3 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Wiley | en_US |
dc.relation.ispartof | European Journal Of Cancer Care | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Prognostic Factors | en_US |
dc.subject | Radiotherapy | en_US |
dc.subject | Renal Cell Carcinoma | en_US |
dc.subject | Retroperitoneal Lymph-Nodes | en_US |
dc.subject | Tumor Size | en_US |
dc.subject | Staging System | en_US |
dc.subject | Survival | en_US |
dc.subject | Classification | en_US |
dc.subject | Impact | en_US |
dc.subject | Validation | en_US |
dc.subject | Invasion | en_US |
dc.subject | Grade | en_US |
dc.subject | Metastases | en_US |
dc.title | Prognostic factors for renal cell carcinoma: Trakya University experience from Turkey | en_US |
dc.type | Article | en_US |